Stockholders' Equity - Additional Information (Detail)
|
|
|
|
1 Months Ended |
3 Months Ended |
6 Months Ended |
|
|
May 20, 2026
USD ($)
$ / shares
shares
|
Apr. 08, 2026
USD ($)
shares
|
Mar. 17, 2026
USD ($)
|
Jun. 30, 2026
USD ($)
Day
$ / shares
shares
|
Jun. 30, 2026
USD ($)
Day
$ / shares
shares
|
Jun. 30, 2026
USD ($)
Day
$ / shares
shares
|
Mar. 31, 2026
USD ($)
shares
|
Mar. 31, 2025
USD ($)
shares
|
Jun. 30, 2026
USD ($)
Day
$ / shares
shares
|
Jun. 30, 2025
USD ($)
|
Dec. 31, 2025
$ / shares
shares
|
| Stockholders Equity Additional Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Common Stock, Shares Authorized | shares |
|
|
|
250,000,000
|
250,000,000
|
250,000,000
|
|
|
250,000,000
|
|
250,000,000
|
| Common Stock, Par or Stated Value Per Share | $ / shares |
|
|
|
$ 0.00001
|
$ 0.00001
|
$ 0.00001
|
|
|
$ 0.00001
|
|
$ 0.00001
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | shares |
|
|
|
|
|
|
|
|
17,582
|
|
|
| Proceeds from Stock Options Exercised | $ |
|
|
|
|
|
|
|
|
$ 4,184
|
$ 375
|
|
| Payments of Stock Issuance Costs | $ |
|
|
|
|
|
|
|
|
$ 452,512
|
$ 396,755
|
|
| Stock Issued During Period, Value, Stock Options Exercised | $ |
|
|
|
|
|
$ 2,925
|
$ 1,260
|
$ 375
|
|
|
|
| Common Stock, Shares, Issued | shares |
|
|
|
11,760,456
|
11,760,456
|
11,760,456
|
|
|
11,760,456
|
|
3,364,984
|
| Sale of Stock, Number of Shares Issued in Transaction | shares |
12,432,021
|
|
|
|
|
|
|
|
|
|
|
| Variable Conversion Price Provision |
|
|
|
|
|
|
|
|
the conversion price becomes the lesser of the Fixed Price and 90% of the lowest daily volume-weighted average price during the ten trading days prior to conversion, subject to a floor price equal to 40% of the Nasdaq Valuation Price
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares |
|
|
|
|
|
|
|
|
$ 0.94
|
|
|
| Notice Period To Terminate Reduced Price Period |
|
|
|
|
|
2 days
|
|
|
|
|
|
| Common Stock, Shares, Outstanding | shares |
|
|
|
11,605,081
|
11,605,081
|
11,605,081
|
|
|
11,605,081
|
|
3,364,984
|
| Treasury Stock, Common, Shares | shares |
|
|
|
155,375
|
155,375
|
155,375
|
|
|
155,375
|
|
|
| Stock Issued During Period, Value, Conversion of Convertible Securities | $ |
|
|
|
|
|
$ 3,791,850
|
|
|
|
|
|
| Loans Payable | $ |
|
|
|
|
|
|
$ 150,000
|
|
|
|
|
| Series C Convertible Preferred Stock Aggregate Liquidation Value | $ |
|
|
|
$ 7,608,720
|
$ 7,608,720
|
$ 7,608,720
|
|
|
$ 7,608,720
|
|
|
| Streeterville Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity Additional Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | shares |
|
|
|
|
|
12,915
|
|
|
|
|
|
| Proceeds from Stock Options Exercised | $ |
|
|
|
|
|
$ 14,211
|
|
|
|
|
|
| Stock Issued During Period, Value, Stock Options Exercised | $ |
|
|
|
|
|
$ 2,925
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares |
|
|
|
|
|
$ 0.92
|
|
|
|
|
|
| Common Shares Issued Upon Exercise Of Warrants | shares |
|
|
|
|
|
84,907
|
|
|
|
|
|
| Stock Issued During Period, Shares, Conversion of Convertible Securities | shares |
|
|
|
|
|
170,766
|
|
|
|
|
|
| Stock Issued During Period, Value, Conversion of Convertible Securities | $ |
|
|
|
|
|
$ 1,938,141
|
|
|
|
|
|
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares |
|
|
|
3,500,000
|
3,500,000
|
3,500,000
|
|
|
3,500,000
|
|
|
| Common Stock Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity Additional Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares |
|
|
|
|
|
|
222,026
|
|
|
|
|
| Class Of Warrant Or Right Number Of Securities Value | $ |
|
|
|
|
|
|
$ 986,226
|
|
|
|
|
| Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity Additional Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Conversion of Stock, Shares Converted | shares |
7,483,093
|
|
|
|
|
|
|
|
|
|
|
| Series C Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity Additional Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Common Stock, Shares, Issued | shares |
|
28,125
|
|
|
|
|
|
|
|
|
|
| Sale of Stock, Consideration Received on Transaction | $ |
|
|
$ 30
|
|
|
|
|
|
|
|
|
| Purchase Of Common Stock | shares |
|
3,500,000
|
|
|
|
|
|
|
|
|
|
| Amount Of Warrant Purchase Price | $ |
|
$ 10,000
|
|
|
|
|
|
|
|
|
|
| Payment of Financing and Stock Issuance Costs | $ |
$ 30,000
|
|
|
|
|
|
|
|
|
|
|
| Conversion Price Percentage Of Lowest VWAP |
|
|
|
90.00%
|
90.00%
|
90.00%
|
|
|
90.00%
|
|
|
| Conversion Price VWAP Lookback Period In Trading Days | Day |
|
|
|
10
|
10
|
10
|
|
|
10
|
|
|
| Conversion Price Floor Percentage Of Nasdaq Valuation Price |
|
|
|
40.00%
|
40.00%
|
40.00%
|
|
|
40.00%
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares |
|
|
|
|
$ 16
|
|
|
|
|
|
|
| Warrant Exercise Price After Reduced Price Period | $ / shares |
|
|
|
$ 16
|
16
|
$ 16
|
|
|
$ 16
|
|
|
| Notice Period To Terminate Reduced Price Period |
|
|
|
2 days
|
|
|
|
|
|
|
|
| Stock Issued During Period, Value, Acquisitions | $ |
$ 6,990,000
|
|
|
|
|
|
|
|
|
|
|
| Series C Convertible Preferred Stock [Member] | Amendment 1 [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity Additional Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares |
|
|
|
|
$ 5
|
|
|
|
|
|
|
| Reduced Exercise Price Applied if Vested In Days | Day |
|
|
|
|
90
|
|
|
|
|
|
|
| Incremental Fair Value From Warrant Modification | $ |
|
|
|
$ 514,313
|
|
|
|
|
|
|
|
| Series C Convertible Preferred Stock [Member] | Amendment 2 [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity Additional Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | $ / shares |
|
|
|
$ 3
|
|
|
|
|
|
|
|
| Reduced Exercise Price Applied if Vested In Days | Day |
|
|
|
90
|
|
|
|
|
|
|
|
| Incremental Fair Value From Warrant Modification | $ |
|
|
|
$ 431,680
|
|
|
|
|
|
|
|
| Conversion of Convertible Notes [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity Additional Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Debt Conversion, Original Debt, Amount | $ |
|
|
|
|
|
$ 2,766,316
|
|
|
|
|
|
| Debt Conversion, Converted Instrument, Shares Issued | shares |
|
|
|
|
|
223,050
|
|
|
|
|
|
| Debt Conversion, Converted Instrument, Type |
|
|
|
|
|
Common Stock
|
|
|
|
|
|
| Conversion Price Percentage Of Qualified Financing Price |
|
|
|
80.00%
|
80.00%
|
80.00%
|
|
|
80.00%
|
|
|
| Series B Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity Additional Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Preferred Stock, Par or Stated Value Per Share | $ / shares |
|
|
|
$ 0.00001
|
$ 0.00001
|
$ 0.00001
|
|
|
$ 0.00001
|
|
$ 0.00001
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity Additional Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | shares |
|
|
|
|
|
12,915
|
4,667
|
2,084
|
|
|
|
| Payments of Stock Issuance Costs | $ |
|
|
|
|
|
|
$ 693,659
|
|
|
|
|
| Stock Issued During Period, Value, Stock Options Exercised | $ |
|
|
|
|
|
|
$ 1,260
|
|
|
|
|
| Stock Issued During Period, Shares, New Issues | shares |
|
|
|
|
|
|
77,776
|
|
|
|
|
| Stock Issued During Period, Shares, Conversion of Convertible Securities | shares |
|
|
|
|
|
223,050
|
|
|
|
|
|
| Stock Issued During Period, Value, Conversion of Convertible Securities | $ |
|
|
|
|
|
$ 2
|
|
|
|
|
|
| Preferred Stock [Member] | Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity Additional Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Stock Issued During Period, Shares, New Issues | shares |
7,000
|
|
|
|
|
|
|
|
|
|
|
| Preferred Stock [Member] | Series C Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity Additional Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Stock Issued During Period, Shares, New Issues | shares |
7,000
|
|
|
|
|
|
|
|
|
|
|
| Payments for Repurchase of Convertible Preferred Stock | $ |
$ 7,000,000
|
|
|
|
|
|
|
|
|
|
|
| Preferred Stock, Par or Stated Value Per Share | $ / shares |
$ 1,086.96
|
|
|
|
|
|
|
|
|
|
|
| Preferred Stock [Member] | Series B Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
| Stockholders Equity Additional Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | shares |
|
|
|
|
|
|
740,328
|
|
|
|
|